PeptidePedia The community reference

Special:RecentChanges

Change log·6,798 revisions·page 63 of 68

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 6,798 changes are logged in total.

6,798Logged changes
575Bot edits
167Page creations
256Active editors

15 September 2024

  1. (diff | hist) 05:15 Insulin secretion 2,712 +352 DeadSpaceDot (talk | contribs) the numbers in the lead disagreed with the body; body was right [rollback]
  2. (diff | hist) 04:08 Receptor bias 1,938 ±0 DeadSpaceDot (talk | contribs) add the species in which the knockout work was done [rollback]
  3. (diff | hist) m 03:21 High-performance liquid chromatography 3,326 +147 Peptide_Pete (talk | contribs) add category for method validation [rollback]

14 September 2024

  1. (diff | hist) m b 21:16 Oral semaglutide 2,129 ±0 ArchiveBot (talk | contribs) bot: expand DOI to full citation [rollback]
  2. (diff | hist) 19:35 Proglucagon 2,929 +227 SatietySunniva (talk | contribs) the glucose-dependence of the insulinotropic effect deserves its own sentence [rollback]
  3. (diff | hist) 18:08 Subcutaneous injection 2,928 +836 BUD_Bertram (talk | contribs) move a stray full stop inside the reference [rollback]
  4. (diff | hist) m 14:34 Chain of custody 2,414 ±0 MarginNoteMars (talk | contribs) add the note that self-submitted reports are a self-selected sample [rollback]
  5. (diff | hist) m 13:36 Limit of detection 2,557 +815 CRP_Cormac (talk | contribs) rm the claim that the method is stability-indicating without a forced-degradation study [rollback]
  6. (diff | hist) m 11:18 Chinese Peptide Company 4,112 +696 NPOV_Nadia (talk | contribs) expand §Product range [rollback]
  7. (diff | hist) N 09:00 Fasting insulin 1,061 +1,061 UnitsUrsula (talk | contribs) start article; reference intervals to follow
  8. (diff | hist) 08:52 Talk:Qingdao Sigma Chemical 1,033 +91 SourceHunterSile (talk | contribs) /* Attributed founding year versus registry record */ reply
  9. (diff | hist) 04:53 Weight regain after discontinuation 1,814 +613 LeanMassLars (talk | contribs) expand §Interpretation [rollback]
  10. (diff | hist) 03:25 Medutest 2,675 +138 GroupBuyGalen (talk | contribs) add the turnaround time the service publishes [rollback]
  11. (diff | hist) m 03:11 Good manufacturing practice 1,773 ±0 GMP_Gita (talk | contribs) add the effective date to the regulatory table [rollback]
  12. (diff | hist) m 00:36 Satiety signalling 2,170 ±0 HalfLifeHavel (talk | contribs) ce, tighten prose [rollback]

13 September 2024

  1. (diff | hist) m 22:44 Mass spectrometry 2,880 ±0 TFA_Counterion (talk | contribs) clarify that mass spectrometry confirms identity, not purity [rollback]
  2. (diff | hist) 20:27 WuXi TIDES 4,395 +179 BlindSampleBrid (talk | contribs) unpipe a link that did not need piping [rollback]
  3. (diff | hist) m 20:04 VendorInvestigate 2,190 ±0 Retention_Time_Rae (talk | contribs) add the retest interval and what triggers one [rollback]
  4. (diff | hist) m 18:59 Research use only 3,193 +314 CagriCass (talk | contribs) split the compounding position from the manufacturing position [rollback]
  5. (diff | hist) 16:08 Area percent purity 2,608 +767 MassSpecMarv (talk | contribs) rm the claim that the method is stability-indicating without a forced-degradation study [rollback]
  6. (diff | hist) 15:52 Dipeptidyl peptidase-4 3,295 ±0 GsCouplingGil (talk | contribs) expand §Catalytic action and substrate range [rollback]
  7. (diff | hist) m 13:34 Residual solvent 1,962 ±0 SigFigSindri (talk | contribs) expand §Classes and limits [rollback]
  8. (diff | hist) m b 12:57 Analytical method validation 2,979 +540 CiteBot (talk | contribs) bot: repair redlinked category [rollback]
  9. (diff | hist) m 12:28 Semaglutide 5,011 +154 GHK_Gwendolen (talk | contribs) rm a duplicated category [rollback]
  10. (diff | hist) 09:54 Certificate of analysis 2,872 ±0 AnalyticalAnnie (talk | contribs) add the second-opinion point: two services, one lot, is a stronger record [rollback]
  11. (diff | hist) N 09:00 Chain of custody 2,414 +2,414 LotTraceLuka (talk | contribs) create article — testing stub

12 September 2024

  1. (diff | hist) 18:58 PeptideMeter 2,054 ±0 NNT_Nerys (talk | contribs) add the note that a purity figure without water and counterion is not a mass [rollback]
  2. (diff | hist) 16:19 LEADER trial 1,120 ±0 PioneerPerdita (talk | contribs) British spelling per PP:MOS [rollback]
  3. (diff | hist) m 14:43 ISO 9001 1,587 ±0 SemaglutideSasha (talk | contribs) expand §What it implies about material [rollback]
  4. (diff | hist) 14:39 Hunan Aslsen Technology 1,699 ±0 TallySheetTad (talk | contribs) add the note that self-published material is usable only for what it states about itself [rollback]
  5. (diff | hist) 11:42 Glucagon-like peptide-1 5,965 +138 SemaglutideSasha (talk | contribs) rm the sentence implying the hormone is a drug [rollback]
  6. (diff | hist) N 10:37 Crude peptide 1,088 +1,088 CDMO_Caradoc (talk | contribs) new article: supply and handling, expansion welcome
  7. (diff | hist) 09:18 Talk:Qingdao Sigma Chemical 822 +111 Hedgerow_Hal (talk | contribs) /* Attributed founding year versus registry record */ reply
  8. (diff | hist) N 09:00 Receptor bias 1,938 +1,938 ChromCleanupCass (talk | contribs) start article on the hormone
  9. (diff | hist) 08:51 Talk:Research use only 822 +129 Compounding_Cate (talk | contribs) /* Should the warning box be a banner instead? */ reply
  10. (diff | hist) 08:06 Batch number 2,461 +468 PurityClaimPia (talk | contribs) expand §Consistency checks [rollback]
  11. (diff | hist) 06:20 Injection site rotation 2,155 +574 INN_Ingrid (talk | contribs) expand §Rotation schemes [rollback]
  12. (diff | hist) 03:06 Reconstitution of lyophilised peptides 2,961 +107 LyophilLena (talk | contribs) state that swirling rather than shaking is the handling convention, sourced [rollback]
  13. (diff | hist) N 02:22 Dulaglutide 1,910 +1,910 StopperingSteff (talk | contribs) new article: compound, expansion welcome

11 September 2024

  1. (diff | hist) 14:03 Talk:Research use only 611 +245 Hedgerow_Hal (talk | contribs) /* Should the warning box be a banner instead? */ reply
  2. (diff | hist) 13:44 Talk:Qingdao Sigma Chemical 611 +242 NotabilityNoa (talk | contribs) /* Attributed founding year versus registry record */ reply
  3. (diff | hist) 10:26 Talk:Qingdao Sigma Chemical 400 +279 SourceHunterSile (talk | contribs) /* Attributed founding year versus registry record */ new section
  4. (diff | hist) 10:26 Talk:Research use only 400 +193 DefinedTermDov (talk | contribs) /* Should the warning box be a banner instead? */ new section
  5. (diff | hist) 00:01 Karl Fischer titration 4,173 +37 INN_Ingrid (talk | contribs) state that ultraviolet response is not uniform across impurities [rollback]

10 September 2024

  1. (diff | hist) 23:18 Glucose-dependent insulinotropic polypeptide 5,034 +688 GsCouplingGil (talk | contribs) clarify that concentrations differ substantially between assay platforms [rollback]
  2. (diff | hist) N 19:51 Injection site rotation 1,581 +1,581 FlowTrialFraser (talk | contribs) new article: dosing and handling, expansion welcome
  3. (diff | hist) 16:58 Reverse-phase HPLC 3,012 ±0 TFA_Counterion (talk | contribs) correct the integration description — valley-to-valley, not drop-line [rollback]
  4. (diff | hist) 16:04 Cold chain 10,238 +1,701 CounterfeitCato (talk | contribs) give the vial sizes in millilitres of nominal capacity [rollback]
  5. (diff | hist) 14:43 Lyophilisation 4,024 +2,061 CDMO_Caradoc (talk | contribs) space between number and unit per PP:MOS [rollback]
  6. (diff | hist) 08:14 Retatrutide 3,350 +38 LiraLotte (talk | contribs) fix a broken wikilink [rollback]
  7. (diff | hist) 05:00 Good manufacturing practice 1,773 +620 TrialsTabitha (talk | contribs) expand §What a GMP claim on a research chemical means [rollback]

9 September 2024

  1. (diff | hist) 23:20 Prescribing information 1,931 ±0 SPPS_Sorrel (talk | contribs) state whether the figure is list price or net of rebate [rollback]
  2. (diff | hist) m b 16:32 C-peptide 1,892 ±0 ArchiveBot (talk | contribs) bot: normalise unit spacing [rollback]
  3. (diff | hist) 14:32 Peptide 3,677 +131 CDMO_Caradoc (talk | contribs) attribute the stability figure to the study and its duration [rollback]
  4. (diff | hist) N 09:00 Hunan Aslsen Technology 1,699 +1,699 BatchNumberBede (talk | contribs) create organisation article per PP:VN
  5. (diff | hist) 04:05 Peptide content 1,273 ±0 AAA_Analyst (talk | contribs) give the injection volume, without which the loading cannot be judged [rollback]
  6. (diff | hist) m 03:19 Tirzepatide 3,866 +141 TitrationTheo (talk | contribs) clarify that the peptide backbone is acylated rather than PEGylated [rollback]

8 September 2024

  1. (diff | hist) 22:10 Oral semaglutide 2,129 +700 PrepHPLC_Pia (talk | contribs) add see also to the amylin analogue [rollback]
  2. (diff | hist) m 15:04 SELECT trial 1,788 ±0 ConsensusConal (talk | contribs) correct the follow-up duration — the source gives weeks, we had months [rollback]
  3. (diff | hist) N 09:00 Prescribing information 1,931 +1,931 HarmReductionHen (talk | contribs) new article: access and cost, expansion welcome
  4. (diff | hist) 08:57 Residual solvent 1,962 +737 NewLabNell (talk | contribs) ce per PP:MOS [rollback]
  5. (diff | hist) m b 05:57 SURMOUNT trial programme 2,536 +479 StubSorterBot (talk | contribs) bot: expand DOI to full citation [rollback]
  6. (diff | hist) m b 05:40 Nantong Guangyuan Chemical 4,284 +1,497 ArchiveBot (talk | contribs) bot: add supplier category [rollback]

7 September 2024

  1. (diff | hist) m 17:56 Glucagon 3,652 +211 SemaglutideSasha (talk | contribs) add the receptor targets to the lead sentence [rollback]
  2. (diff | hist) 17:13 Amylin 1,269 ±0 CagriCass (talk | contribs) the half-life in the lead was the terminal figure; label it as such [rollback]
  3. (diff | hist) m b 11:28 Chinese Peptide Company 3,416 +747 ArchiveBot (talk | contribs) bot: update parent category chain [rollback]
  4. (diff | hist) N 10:01 VendorInvestigate 2,190 +2,190 CheckSumChase (talk | contribs) new article: testing and documentation, expansion welcome
  5. (diff | hist) 08:20 Loss on drying 1,765 +534 SigFigSindri (talk | contribs) British spelling per PP:MOS [rollback]
  6. (diff | hist) N 01:30 Peptide content 1,273 +1,273 PeakShapePol (talk | contribs) start article on the analytical method

6 September 2024

  1. (diff | hist) m 21:15 Reconstitution calculator 1,365 ±0 SafetySignalSid (talk | contribs) state the diluent volume the default assumes [rollback]
  2. (diff | hist) 13:33 Area percent purity 1,841 +33 TechnicianTeal (talk | contribs) add the peptide-content point: area percent alone cannot give a mass [rollback]
  3. (diff | hist) m 13:29 Cagrilintide 1,887 ±0 SemaglutideSasha (talk | contribs) the lead claimed weekly dosing for a compound dosed daily; corrected [rollback]
  4. (diff | hist) 07:54 WuXi TIDES 4,216 +1,176 Chromatokid (talk | contribs) expand the product-scope row in the infobox [rollback]
  5. (diff | hist) m 04:08 Albumin binding half-life extension 2,425 ±0 DPP4_Dagmar (talk | contribs) give the magnitude of the incretin effect as a percentage of the insulin response [rollback]
  6. (diff | hist) 03:46 Insulin syringe 2,620 +280 IncretinIvo (talk | contribs) add the preservative point: unpreserved diluent changes the interval [rollback]
  7. (diff | hist) 00:09 SUSTAIN trial programme 2,824 +253 SurmountSurma (talk | contribs) add the year of publication to each trial in the list [rollback]

5 September 2024

  1. (diff | hist) 21:00 Resin cleavage 2,085 +407 StopperingSteff (talk | contribs) add the collapse-temperature point, sourced [rollback]
  2. (diff | hist) m 17:12 Electrospray ionisation 1,326 ±0 Chromatokid (talk | contribs) add the note on co-elution and what it hides [rollback]
  3. (diff | hist) m b 16:49 Certificate of analysis 2,872 +1,014 ArchiveBot (talk | contribs) bot: normalise citation format [rollback]
  4. (diff | hist) 15:40 PeptideMeter 2,054 ±0 BlankVialBo (talk | contribs) rm the aggregate pass-rate figure; the denominator is not knowable [rollback]
  5. (diff | hist) 10:26 Hypoglycaemia 2,014 +235 MTC_Marisol (talk | contribs) add the interaction with the mechanism that explains it [rollback]
  6. (diff | hist) 10:23 Adverse effects of GLP-1 receptor agonists 3,137 +523 RegainRomilly (talk | contribs) rm the causal wording — spontaneous reports do not establish causation [rollback]
  7. (diff | hist) N 09:10 Weight regain after discontinuation 1,201 +1,201 StopperingSteff (talk | contribs) new article: adverse effects, expansion welcome
  8. (diff | hist) 07:05 Sterile water for injection 1,810 ±0 SyringeSybille (talk | contribs) correct the label on the second column — that is volume, not mass [rollback]
  9. (diff | hist) 06:22 Retention time 1,620 +634 MoveRequestMio (talk | contribs) expand §Reporting on certificates [rollback]
  10. (diff | hist) 05:54 Intention-to-treat analysis 2,167 +200 OpenLabelOtto (talk | contribs) state that the trial has reported but is not yet peer-reviewed [rollback]
  11. (diff | hist) 04:33 Liraglutide 2,493 ±0 DMF_Dermot (talk | contribs) correct the dose ladder — the maintenance dose is not the maximum dose [rollback]
  12. (diff | hist) m 00:56 Wuhan Wansheng Biotechnology 5,196 +885 BlankVialBo (talk | contribs) add the how-to-request-a-batch-record sentence to §Ordering and availability [rollback]

4 September 2024

  1. (diff | hist) 20:19 Incretin effect 3,698 ±0 LCellLeif (talk | contribs) distinguish the active and total forms of the hormone throughout [rollback]
  2. (diff | hist) 17:09 GLP-1 receptor agonist 5,536 +123 MolarMassMaeve (talk | contribs) consistent en dashes in ranges [rollback]
  3. (diff | hist) 15:27 Talk:Glucagon-like peptide-1 1,033 +197 Hedgerow_Hal (talk | contribs) /* Residue numbering — (7–36) versus (1–30) */ reply
  4. (diff | hist) N 11:33 Reconstitution calculator 1,365 +1,365 ConsensusConal (talk | contribs) start the calculator page — arithmetic first, prose to follow
  5. (diff | hist) 11:22 Talk:Certificate of analysis 1,033 +70 COA_Colwyn (talk | contribs) /* Is "a claim by its issuer" too strong? */ reply
  6. (diff | hist) N 09:41 Albumin binding half-life extension 2,425 +2,425 NPOV_Nadia (talk | contribs) start article on the hormone
  7. (diff | hist) 09:02 Talk:Glucagon-like peptide-1 822 +124 MolarMassMaeve (talk | contribs) /* Residue numbering — (7–36) versus (1–30) */ reply
  8. (diff | hist) 07:02 Vial 6,759 ±0 ResinRhoswen (talk | contribs) de-duplicate a repeated sentence [rollback]
  9. (diff | hist) 04:46 Preparative HPLC purification 2,270 +280 MetricMabel (talk | contribs) add the reconstitution-stability sentence with its storage condition [rollback]
  10. (diff | hist) m 00:22 Bacterial endotoxin test 2,127 ±0 EndotoxinEd (talk | contribs) add the peptide-content point: area percent alone cannot give a mass [rollback]

3 September 2024

  1. (diff | hist) 21:18 GL Biochem (Shanghai) 5,319 ±0 SPPS_Sorrel (talk | contribs) rm the discount code added by an anonymous editor [rollback]
  2. (diff | hist) m 21:04 List of GLP-1 receptor agonists 1,884 ±0 NavboxNiko (talk | contribs) add the category the list itself belongs in [rollback]